David Windley
Stock Analyst at Jefferies
(3.65)
# 802
Out of 4,918 analysts
191
Total ratings
67.89%
Success rate
14.13%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Initiates: Hold | $263 | $226.87 | +15.93% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.74 | +58.05% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $25.91 | +135.43% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $13.58 | -11.63% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $247.26 | +2.32% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $5.46 | +284.62% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $423.09 | -18.46% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $262.23 | +60.93% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $155.13 | +91.45% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $182.45 | +32.64% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $481 → $647 | $237.77 | +172.11% | 26 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $1.92 | +95.31% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $274.66 | +119.91% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $483.12 | -22.38% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $11.15 | +39.01% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $281.35 | -4.03% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.54 | +62.47% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $239.26 | +124.02% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $25.12 | +15.45% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $166.91 | +21.62% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $166.44 | +81.45% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $6.94 | +3,473.49% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.44 | - | 5 | Oct 9, 2017 |
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $226.87
Upside: +15.93%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.74
Upside: +58.05%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $25.91
Upside: +135.43%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $13.58
Upside: -11.63%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $247.26
Upside: +2.32%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $5.46
Upside: +284.62%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $423.09
Upside: -18.46%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $262.23
Upside: +60.93%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $155.13
Upside: +91.45%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $182.45
Upside: +32.64%
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $237.77
Upside: +172.11%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.92
Upside: +95.31%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $274.66
Upside: +119.91%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $483.12
Upside: -22.38%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $11.15
Upside: +39.01%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $281.35
Upside: -4.03%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.54
Upside: +62.47%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $239.26
Upside: +124.02%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $25.12
Upside: +15.45%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $166.91
Upside: +21.62%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $166.44
Upside: +81.45%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $6.94
Upside: +3,473.49%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.44
Upside: -